Marinaki Vassiliki, Lambrou George I
Fifth Orthopedic Department & Spinal Cord Injury Department, "KAT" Hospital, Nikis 2, Kifisia.
First Department of Pediatrics, Choremeio Research Laboratory, National and Kapodistrian University of Athens, Greece.
J Frailty Sarcopenia Falls. 2017 Sep 1;2(3):58-61. eCollection 2017 Sep.
Sarcopenia is a combination of a progressive and generalized loss of skeletal muscle mass and muscle strength or physical performance, with high risk of adverse outcomes such as physical disability, poor quality of life and death. It mainly affects older people, aged 60-70 years. The development of sarcopenia is multifactor. The first step towards the management of sarcopenia is the proper and professional diagnosis. According to EWGSOP the diagnosis of sarcopenia depends on the presence of low muscle mass (LMM) plus low muscle strength (LMS) or low physical performance (LPP). Although it is difficult to establish its prevalence, the higher prevalence is observed in hospitalized elderly patients. It has direct and indirect impact on public health, which are difficult to be measured due to numerous negative outcomes of sarcopenia.
肌肉减少症是骨骼肌质量、肌肉力量或身体机能进行性和全身性丧失的一种综合表现，具有身体残疾、生活质量差和死亡等不良后果的高风险。它主要影响60至70岁的老年人。肌肉减少症的发展是多因素的。管理肌肉减少症的第一步是进行恰当和专业的诊断。根据欧洲老年人肌肉减少症工作组（EWGSOP）的标准，肌肉减少症的诊断取决于低肌肉量（LMM）加上低肌肉力量（LMS）或低身体机能（LPP）。尽管很难确定其患病率，但在住院老年患者中观察到较高的患病率。它对公众健康有直接和间接影响，由于肌肉减少症的众多负面后果，这些影响难以衡量。
